Prevalence and risk factors accounting for true silent myocardial ischemia: A pilot case-control study comparing type 2 diabetic with non-diabetic control subjects

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Hernández, Cristina ^a,b,c   Candell Riera, Jaume ^b,c   Ciudin, Andreea ^c   Francisco, Gemma ^c   Aguadé Bruix, Santiago ^b,c   Simó, Rafael ^a,b,c,d  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; PREDICTION; PREVALENCE; PROBABILITY; PROSPECTIVE STUDY; SEX DIFFERENCE; SILENT MYOCARDIAL ISCHEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT DEPRESSION; AGED; ASYMPTOMATIC DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEART INFARCTION; METHODOLOGY; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; RISK; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; SPAIN; STATISTICAL MODEL;

AGED; ASYMPTOMATIC DISEASES; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; ODDS RATIO; PILOT PROJECTS; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPAIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 78651536775     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-9     Document Type: Article

References (27)

1. Cosson E, Attali JR, Valensi P. Markers for silent myocardial ischemia in diabetes. Are they helpful?. Diabetes Metab 2005, 31:205-213. 10.1016/S1262-3636(07)70187-8, 15959427.
2. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE, . Detection of Ischemia in Asymptomatic Diabetics Investigators Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects, The DIAD Study. Diabetes Care 2004, 27:1954-1961. 10.2337/diacare.27.8.1954, 15277423, Detection of Ischemia in Asymptomatic Diabetics Investigators.
3. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, . STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007, 370:1453-1457. 10.1016/S0140-6736(07)61602-X, 18064739, STROBE Initiative.
4. Candell-Riera J, Santana-Boado C, Bermejo B, Castell-Conesa J, Aguadé-Bruix S, Canela T, Soler-Soler J. Prognosis of "clandestine" myocardial ischemia, silent myocardial ischemia, and angina pectoris in medically treated patients. Am J Cardiol 1998, 82:1333-1338. 10.1016/S0002-9149(98)00637-7, 9856915.
5. Candell-Riera J, Romero-Farina G, Arenillas JF, Aguadé-Bruix S, de León G, Castell-Conesa J, Molina CA, Montaner J, Rovira A, Álvarez-Sabín J. Prognostic value of myocardial perfusion gated SPECT in patients with symptomatic intracranial large artery atherosclerosis. Cerebrovasc Dis 2007, 24:247-254. 10.1159/000104486, 17630486.
6. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, Van Train KF, Berman DS. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995, 36:2138-2147.
7. Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, . Global Diabetic Retinopathy Project Group Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110:1677-1682. 10.1016/S0161-6420(03)00475-5, 13129861, Global Diabetic Retinopathy Project Group.
8. Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol 2005, 45:43-49. 10.1016/j.jacc.2004.06.078, 15629371.
9. Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 2006, 47:65-71. 10.1016/j.jacc.2005.10.008, 16386666.
10. Cheung N, Wang JJ, Klein R, Couper DJ, Sharrett AR, Wong TY. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care 2007, 30:1742-1746. 10.2337/dc07-0264, 17389333.
11. Cheung N, Wong TY. Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 2008, 2:161-76.
12. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010, 376:124-36. 10.1016/S0140-6736(09)62124-3, 20580421.
13. Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 2007, 30:292-9. 10.2337/dc06-1747, 17259497.
14. Liew G, Wong TY, Mitchell P, Cheung N, Wang JJ. Retinopathy predicts coronary heart disease mortality. Heart 2009, 95:391-4. 10.1136/hrt.2008.146670, 18697802.
15. Rema M, Mohan V, Deepa R, Ravikumar R. Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy: the Chennai Urban Rural Epidemiology Study (CURES-2). Diabetes Care 2004, 27:1962-1967. 10.2337/diacare.27.8.1962, 15277424.
16. Young LH, Wackers FJ, Chyun DA, et al. DIAD Investigators Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 2009, 301:1547-1555. 10.1001/jama.2009.476, 2895332, 19366774, DIAD Investigators.
17. Faglia E, Manuela M, Antonella Q, Michela G, Vincenzo C, Maurizio C, Roberto M, Alberto M. Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. Am Heart J 2005, 149:e1-6. 10.1016/j.ahj.2004.07.027, 15846252.
18. Mohagheghie A, Ahmadabadi MN, Hedayat DK, Pourbehi MR, Assadi M. Myocardial perfusion imaging using technetium-99 m sestamibi in asymptomatic diabetic patients. Nuklearmedizin 2010,
19. Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol 2007, 49:227-237. 10.1016/j.jacc.2006.08.048, 17222734.
20. Wackers FJ, Chyun DA, Young LH, Heller GV, Iskandrian AE, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Filipchuk N, Ratner RE, Inzucchi SE, . Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. Diabetes Care 2007, 30:2892-2898. 10.2337/dc07-1250, 17682123, Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators.
21. Andersson C, Gislason GH, Weeke P, Hoffmann S, Hansen PR, Torp-Pedersen C, Søgaard P. Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease. Cardiovasc Diabetol 2010, 9:3. 10.1186/1475-2840-9-3, 2818623, 20082690.
22. Hallén J, Johansen OE, Birkeland KI, Gullestad L, Aakhus S, Endresen K, Tjora S, Jaffe AS, Atar D. Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus. Cardiovasc Diabetol 2010, 9:52. 2946276, 20843304.
23. Shirani J, Dilsizian V. Screening asymptomatic patients with type 2 diabetes mellitus for coronary artery disease: does it improve patient outcome?. Curr Cardiol Rep 2010, 12:140-146. 10.1007/s11886-010-0091-z, 20425169.
24. Simó R, Hernández C. Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia 2008, 51:1574-1580.
25. Simó R, Hernández C. Advances in the medical treatment of diabetic retinopathy. Diabetes Care 2009, 32:1556-62. 2713619, 19638526.
26. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP, King GL. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002, 105:373-9. 10.1161/hc0302.102143, 11804995.
27. Wirostko B, Wong TY, Simó R. Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res 2008, 27:608-21. 10.1016/j.preteyeres.2008.09.002, 18929676.